BACKGROUND In hemodialyzed patient, we can often seethe complication (ex. Hypotension, bad feeling) in hemodialysis (HD) after cardiac catheterization. So we made modification for HD after the first time cardiac catheterization. Content of the modify HD are that the blood osmolality was changed slowly.
METHODS
The candidate was our consecutive HD patients (218 patients, 157 male, 67.1 AE 9.8 y.o.) who performed cardiac catheterization from February 2009 to August 2014 . From February 2009 to December 2012 we performed usual HD after cardiac catheterization (HD group: 157 patients) . From January 2013 to August 2014 we performed modified HD after that (mHD group: 61 patients). Content of modify were that we decreased dialysis flow rate (300 ml/min) in anterior half of HD; in posterior half we performed ordinary HD. The definition of the complication are discontinuity of HD from hypotension or/and bad feeling, Unattainable of defecated water and requisition of infusion solution.
RESULTS Developed the complication of HD group was 59 patients (37.6 %), mHD group was 7 patients (11.3 %). It was significant difference between the groups (p¼0.00013).
CONCLUSION Our Modifying, the blood osmolality was changed slowly, of HD after the first time cardiac catheterization was useful for reducing the rate complication. The procedure could not be completed in one patient due to hemodynamically unstable incessant ventricular tachycardia. Subsequently 35 patients were followed up for next 5 years both clinically and with echocardiography.
HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY

RESULTS
The mean age at intervention was 32AE10 years. The peak dynamic LVOT gradient pre-operatively was 73AE20 mm Hg. Alcohol septal ablation was performed successfully in all 35 patients with immediate LVOT gradient reduction. The peak LVOT gradient postoperatively was 13AE7 mm of Hg. Three patients developed complete heart block during the procedure, among which 2 patients reverted back spontaneously to sinus rhythm within 72 hours. One patient did not revert back and permanent pacemaker was implanted. Over next 5-8 years follow up 4 patients died (2 patients with refractory heart failure, 2 patients with sudden cardiac death). Three patients developed atrial fibrillation over follow up. Rest of the patients is doing well symptomatically and echocardiography showed no recurrence of significant LVOT obstruction.
CONCLUSION HCM is a complex genetic disorder with several long term complications especially in the obstructive variety. Though it is said to reserve alcohol septal ablation (Class IIa) only for those who are not suitable candidates for surgical mectomy, a large group of symptomatic patients who refuse for surgical option can also be treated successfully with alcohol septal ablation. The immediate and long-term outcome is good. BACKGROUND Thoracic endovascular aortic repair (TEVAR) shows limitations in cases where the aortic pathology involves the aortic arch and only a short proximal landing zone is thereby available for the stent graft. In our previous study, we developed a round shape fenestrated aortic arch stent graft (FASG) with a preloaded catheter for protecting branch arteries. But, FASG with round shape fenestration is not available in case of emergency as aortic rupture, complicated aortic dissection because FASG with round shape fenestration is manufactured individually. In this study, we developed a window shape FASC with a preloaded catheter for protecting branch arteries and performed a preclinical study with this device in swine.
INNOVATIVE DEVICES AND FUTURISTIC THERAPIES
METHODS
The FASG is a self-expandable nitinol-PTEF stent graft with window shape fenestration and preloading catheter that is designed to access right carotid artery safely. We design a window shaped fenestration and preloading catheter placed inside the stent graft to save blood flow to the carotid, left subclavian arteries. After window shape FASG is partially deployed, 0.35 inch guidewire is placed into the right carotid artery and then stent graft is fully deployed. Following separate stent graft for right carotid artery is deployed. The sizes of fenestrated window were 30mm in width, 15mm in length and 40mm in width, 15mm in length. Six FASGs with window shaped fenestration and a side branch stent graft were advanced through the iliac artery in 6 swines weighing 70-80 kg. The presence of endoleaks and the patency and deformity of the grafts were examined with digital subtraction angiography (DSA) at 4 weeks postoperatively. A postmortem examination was performed at 8 weeks to evaluate the gross morphology, patency, and deformity of the FASGs with window shaped fenestration.
RESULTS
The mean procedure time for the FASG with window shaped fenestration was 23.0 AE 6.0 minutes. Meanwhile, the mean time for the selection of the right carotid artery was 3.6 AE 0.9 minutes. There was no major adverse event in the 6 pigs. Six pigs survived the 8-weeks observational period. For FASGs with window shaped fenestration, no endoleaks, no disconnection of the stent grafts, and no occlusion of the stent grafts for the carotid arteries were observed in the DSA at 4 weeks. Moreover, no disconnection or tearing of the stent grafts, no fractures in the stent grafts, and no occlusion of the stent graft for carotid arteries were found in the postmortem gross findings.
CONCLUSION The window shape FASG with the preloaded catheter developed for emergency was found to be safe and convenient to use in this preclinical study with swine. Readymade window shape FASGs which have several sized fenestrated window can be applied in case of emergency. BACKGROUND Although it is well known that the chronic kidney disease (CKD) is a key factor for CIN, the effective therapy for the prevention of CIN especially in advanced CKD-Patients has not been established so far. Recently, it was reported that continuous hemofiltration (CHF) could prevent CIN and reduce in-hospital mortality in advanced CKD-patients via both filtrating contrast and administration of alkaline agents. However, this method requires a long durationtime (18 to 30 hours) because of its low removal efficiency. Applying this principle, we established a novel continuous hemodiafiltration (CHDF) technique to get more effective blood clarification which promotes replacement and dialysate flow up to 5 times compared to standard CHDF. By using this method we demonstrated that the required time for 99 % removal of contrast could be shorten to one sixth (about 4.5 hours) in our vitro experiment and named this procedure as High-flow CHDF (HF-CHDF). In this report, we performed HF-CHDF in clinical application for advanced CKD-Patients required intervention.
METHODS We retrospectively analyzed the incidence of CIN in consecutive 43 advanced CKD patients (8 in stage3b, 33 in stage4, and 2 in stage5) from Jan. 2009 to Dec. 2013. In addition of 0.9 % saline hydration, HF-CHDF was performed from just before the procedure until 2.5 hours after intervention in all patients. We defined CIN as sCre increase over 25 % from the baseline value at the point of 1 month after intervention.
RESULTS At baseline, mean serum creatinine (sCre) was 2.31 AE 0.62 mg/dl, and mean eGFR was 24.0 AE 6.5 ml/min/1.73m2. And, sCre was 2.29 AE 0.79 mg/dl, eGFR 25.6 AE 9.6 ml/min/1.73m2 at 1 month after procedure. The incidence of CIN was 4.6% (2 in 43), which was remarkably lower than previous reports (the incidence of CIN by hydration only was 15-20%, by alkaline agents was 10-15%). Rate of occurrence requiring permanent HD due to CIN within 1year was 2.3%.
CONCLUSION HF-CHDF method during and after PCI and PPI procedure which we have established could be new standard for preventing CIN in advanced CKD-patients required intervention. Following this pilot study, multi-center trial is now ongoing to construct further evidence in Japan. 
